• Complement Component C1q
  • Chromosome Analysis, Amniotic Fluid
  • Hepatitis A Virus (HAV) Antibody, IgM
  • DetermaRx for Lung Cancer Disease Management
  • 17-Hydroxypregnenolone, Serum
  • B and T Cell Gene Rearrangement, Bone Marrow
  • Myeloid Differentiation Primary Response 88 (MYD88) Gene Mutation Analysis
  • Retinal Detachment
  • Cytochrome P450 3A7 (CYP3A7) Genotyping
  • Myosin regulatory light chain 2 (MYL2) Gene Mutation Analysis
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /FoundationFocus CDxBRCA
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

FoundationFocus CDxBRCA
Medical Test

Methodology
Access to FoundationFocus CDxBRCA is restricted.